Citizens National Bank Trust Department Decreases Holdings in CVS Health Co. (NYSE:CVS)

Citizens National Bank Trust Department decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 27.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,050 shares of the pharmacy operator’s stock after selling 795 shares during the period. Citizens National Bank Trust Department’s holdings in CVS Health were worth $92,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health during the 3rd quarter valued at $25,000. Ridgewood Investments LLC grew its position in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new position in CVS Health in the 4th quarter worth $28,000. Legacy Investment Solutions LLC bought a new position in CVS Health in the 3rd quarter worth $31,000. Finally, Reston Wealth Management LLC bought a new position in CVS Health in the 3rd quarter worth $32,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CVS shares. Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $55.00 to $75.00 in a report on Thursday, February 13th. Wells Fargo & Company upped their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a report on Thursday, February 13th. Royal Bank of Canada dropped their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a report on Tuesday. Finally, Leerink Partnrs raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 12th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $70.00.

Insider Buying and Selling

In related news, Director Michael F. Mahoney bought 30,000 shares of CVS Health stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Stock Down 1.8 %

Shares of NYSE CVS opened at $65.20 on Friday. The firm’s 50-day moving average price is $52.11 and its 200-day moving average price is $56.18. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $82.21 billion, a price-to-earnings ratio of 17.81, a P/E/G ratio of 0.98 and a beta of 0.61. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, equities research analysts anticipate that CVS Health Co. will post 5.91 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.08%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.